Myasthenia Gravis: The Role of Apheresis

In this month’s episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews Jeffrey Winters, M.D., the medical director of the Therapeutic Apheresis Treatment Unit at Mayo Clinic for Myasthenia Gravis Awareness Month. 

Discussion includes:

  • Apheresis and myasthenia gravis.
  • Short-term versus long-term apheresis treatment.
  • Improvements for treating myasthenia gravis patients.

Podcast episode

Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.

Follow or subscribe to this podcast

Listen today through your favorite podcast platform:
apple podcasts icon square 110x110APPLE PODCASTS | Spotify icon square 110x110SPOTIFY | Google Podcasts icon square 110x110GOOGLE PODCASTS | Amazon Music icon square 110x110AMAZON MUSIC | Stitcher icon square 110x110STITCHER | YouTube icon square 110x110YOUTUBE | RSS icon square 110x110RSS LINK

Podcast episode in video format

More from Lab Medicine Rounds

A Mayo Clinic-curated podcast for physicians, laboratory professionals, students, hosted by Dr. Justin Kreuter, assistant professor of laboratory medicine and pathology at Mayo Clinic, and featuring trending educational topics from subject matter experts.

MCL Education

This post was developed by our Education and Technical Publications Team.